Seth Alpna
Keros Therapeutics, Inc. · Director
Seth Alpna is listed in filings as Director at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS) and Bio-Techne Corp (TECH). The current snapshot covers public activity from Oct 28, 2024 to Jun 5, 2026. Reported amounts are shown as $28.1K to $230.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $28k2.6k shares | SellJun 4, 2026 | $10.72 | $10.61 |